Streduxo Trademark Details

Streduxo was registered on Tuesday, November 3, 2015 and is currently owned by Sanofi under the registration number 4846023 . This mark is alive with a status of Registered. The last case file activity for this mark occured 8 years ago on Tuesday, November 3, 2015, according to the United State Patent & Trademark Office
Word Mark Streduxo
Status Alive Registered 700 — Registered

Current Owner

Sanofi of Paris, TX

View all trademarks for Sanofi
Other Trademarks for Sanofi
Serial Number 86600317
Registration Number 4846023
Status Date Tuesday, November 3, 2015
Filing Date Tuesday, November 3, 2015
Registration Date Tuesday, November 3, 2015
Attorney Susan Upton Douglass
Domestic Representative Susan Upton Douglass

Correspondent

SUSAN UPTON DOUGLASS
Fross Zelnick Lehrman & Zissu, P.C.
866 United Nations Plz
New York, NY 10017-1822

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, blood disorders, cardiovascular diseases and disorders, cholesterol disorders, lipid disorders, cerebrovascular diseases and disorders, infectious diseases, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders, rheumatoid arthritis and ankylosing spondylarthritis

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Friday, April 24, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.